Recruiting
Pancreatic carcinoma metastatic
RecruitingPhase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
Registered drugNo placebo
Phase 3 Study of atebimetinib with gemcitabine and paclitaxel versus gemcitabine and paclitaxel in patients with metastatic pancreatic cancer
Registered drugNo placebo
- Disease:Pancreatic carcinoma metastatic
- Substances:AtebimetinibPaclitaxel+1
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Atebimetinib



